跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ALS-4
首页
药物
ALS-4
ALS-4
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
(2-(4-(1-(BENZO[D]THIAZOL-5-YL)ETHYL)PIPERAZIN-1 -YL)PYRIMIDIN-5-YL)(IMINO)(METHYL)-LAMDA6-SULFANONE FOR USE IN THE TREATMENT OF COLITIS, PARKINSON DISEASE, TAUOPATHY, ALS AND ALZHEIMER'S DISEASE
申请人: ASCENEURON SA
优先权: 2023
WO
Application of L-arabinoic acid-1, 4-lactone in preparation of medicine for treating gradual freezing
申请人: UNIV CAPITAL MEDICAL SCIENCES
优先权: 2026
CN
Method for treating amyotrophic lateral sclerosis
申请人: BODYBIO INC
优先权: 2004
US
2 件公开
THE PEPTIDOMIMETIC COMPOUND (R)-2-AMINO-N-((S)-L-(((S)-5-AMINO-L-(3-BENZYL-1,2,4-OXADIAZOL-5-YL)PENTYL)AMINO)-3-(4-HYDROXY-2,6-DIMETHYLPHENYL)-1-OXOPROPAN-2-YL)-5-GUANIDINOPENTANAMIDE FOR USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
申请人: STEALTH BIOTHERAPEUTICS INC
优先权: 2019
CN
EP
US
WO
9 件公开
Oromucosal film preparation
申请人: SAPIOTEC GMBH
优先权: 2014
EP
SUBSTITUTED BENZYL-4-AMINOPICOLINIC ACID ESTERS AND PYRIMIDIN-4-CARBOXYLIC ACID ESTER, PROCESS FOR THEIR PREPARATION AND USE AS HERBICIDES AND REGULATORS OF PLANT GROWTH
申请人: BAYER CROPSCIENCE AG
优先权: 2017
EP
COMBINATION THERAPY FOR USE IN TREATING AMYOTROPHIC LATERAL SCLEROSIS USING PRIDOPIDINE AND CNM-AU8 NANOCRYSTALLINE GOLD
申请人: PRILENIA NEUROTHERAPEUTICS LTD
优先权: 2020
EP
2 件公开
Model for simulating ALS constructed based on CASP4 and its construction method
申请人: UNIV JINAN
优先权: 2024
CN
US
2 件公开
药物
反馈